Navigation Links
AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer
Date:9/17/2007

Healthcare Veteran Joins Company's Executive Team

VIRGINIA BEACH, Va., Sept. 17 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) today announced that Mary McCluskey, MD, has been named Chief Medical Officer to oversee healthcare services for the Company's 1.5 million members.

"We are excited to welcome Dr. McCluskey to AMERIGROUP," said James G. Carlson, AMERIGROUP President and Chief Executive Officer. "Throughout her career, she has distinguished herself as an attending clinician, physician executive and leader of a major healthcare organization. She has the experience and the commitment to help AMERIGROUP expand its mission of bringing quality healthcare to the financially vulnerable, seniors and people with disabilities."

"I'm honored to join such an experienced team and to assist AMERIGROUP and the 1.5 million members it serves," McCluskey said. "This is an exciting time for the Company, and I look forward to contributing to its efforts of bringing quality care and service coordination to those who need it most."

For the past eight years, Dr. McCluskey has served in a variety of senior medical positions with Aetna Inc., most recently as Chief Medical Officer, Northeast Region. In this role, she was the senior clinical and medical quality leader for a division that provided health insurance for 2.4 million people through employer-sponsored and Medicare programs. Under her guidance, the company's Northeast region earned an excellent accreditation rating from the National Committee for Quality Assurance. Her previous positions at Aetna included National Medical Director/Head of Clinical Cost Management and Senior Regional Medical Director, Southeast Region.

Prior to Aetna, McCluskey was Vice President of Medical Affairs for Medpartners Medical Management in Tampa. She previously served as Internist/Medical Director of Bridgeton Health Center in St. Louis. McCluskey began her career as an Urgent Care Physician in St. Louis. A graduate of St. Louis University and the St. Louis University School of Medicine, she completed her residency in Internal Medicine at Jewish Hospital/Washington University in St. Louis.

AMERIGROUP offers disease management programs for 11 different conditions, ranging from asthma and diabetes to AIDS and schizophrenia, eight of which are accredited by the National Committee for Quality Assurance. The Company's health plan in the District of Columbia has also obtained accreditation and a rating of commendable from the NCQA. All AMERIGROUP health plans in the District and nine states offer members a range of initiatives that are designed to connect the 1.5 million members with quality, preventive healthcare programs that target the specific needs of low-income Americans.

About AMERIGROUP Corporation

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves more than 1.5 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New York, Ohio, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com .

CONTACTS:

Investors: Julie Loftus Trudell News Media: Kent Jenkins, Jr.

AMERIGROUP Corporation AMERIGROUP Corporation

Senior Vice President, Senior Vice President,

Investor Relations Communications

(757) 321-3597 (757) 518-3671


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
2. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
3. Gene Bias: Onomastics of Shared Surnames among Men Reveals Genetic links
4. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
5. Health Minister Wants Names of Uncooperative Hospital Consultants
6. Chinese PLA Names Bogus Army Medical Bodies Selling Fake Drugs
7. Over 50 Vietnamese Girls Faint Due to Mass Hysteria
8. All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007
9. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
10. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
11. EU medical chief says Europe ready for bird flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... Attorney Robert “RC” Pate , founder of The Law ... Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. ... the effect of the critical funding gap for research into pediatric cancer research. From ...
(Date:1/19/2017)... ... 2017 , ... The CHP suggests that California drivers can avoid hydroplaning as ... and increasing the space between themselves and other vehicles, according to a January 3 ... R. Hassanlou notes that, rain or shine, drivers should always incorporate safe driving practices ...
(Date:1/19/2017)... ... January 19, 2017 , ... The 21st Century Cures Act’s Impact ... Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          ... Act in order to thrive this year? , The passage of the act means ...
(Date:1/19/2017)... ... January 19, 2017 , ... Infinity® Massage Chairs announced today ... implement new sales and marketing strategies. Grover comes with a total of 15 years ... a half years as Executive Vice President of Direct Sales at Traeger® Wood Pellet ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for ... people know that popular cosmetic fillers can enhance earlobes and rejuvenate ... director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017  Kratom leaves, from a ... are often used to prepare tea-like beverages and ... million Americans annually to increase alertness, enhance well-being ... for minor aches and pains. PinneyAssociates, review of ... to assist FDA and DEA in determining the ...
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... , Suiza, 18 de enero de 2017  Hoy, ... lanzaron Access Accelerated, una iniciativa global para avanzar el ... y atención en países de renta baja y baja-media ... alcanzado un punto de crisis, particularmente en países de ... 80 por ciento de las muertes relacionadas con NCD. ...
Breaking Medicine Technology: